Diabetes

Top Story

Starting metformin reduces risks for CV events, death in type 2 diabetes

April 20, 2017

The risks for cardiovascular events and death are decreased 6 months after metformin initiation among adults with type 2 diabetes who experience a large initial HbA1c reduction and reach HbA1c less than 6.5%, according to findings from researchers in Denmark.

Reimar Wernich Thomsen, MD, PhD, consultant and clinical associate professor in the department of clinical epidemiology at Aarhus University Hospital in Denmark, and colleagues evaluated data from patient registries in Northern Denmark on all adults (mean age, 62.5 years; 55% men) with type 2 diabetes who initiated metformin (n = 24,752) between 2000 and 2012 to determine the effect of metformin on HbA1c level and effect of HbA1c reduction on subsequent risk for CV events or death.

In the Journals Plus

Declines in CV events, mortality comparable between adults with diabetes, general population

April 17, 2017
Mortality and incidence of cardiovascular outcomes decreased in Sweden from 1998 to 2014 in adults with diabetes. Although rates of nonfatal cardiovascular events…

Cardiology Today's top stories covered at the ACC Scientific Session

April 13, 2017
The American College of Cardiology Scientific Session featured important late- break ing clinical trials and other material presented by some of the world’s…
In the Journals Plus

Statin use reduces risk for lower-limb amputation in type 2 diabetes, PAD

April 12, 2017
In adults with type 2 diabetes and peripheral artery disease, statin use was associated with a 25% lower rate of lower-extremity amputations and a 22% risk reduction in…
Meeting News

EXCEL: PCI may be acceptable in patients with diabetes, less complex left main CAD

March 17, 2017
WASHINGTON, D.C. — Three-year data from the EXCEL trial indicate that PCI with an everolimus-eluting stent may be acceptable or even preferable…

AMA, ACS, AHA, ADA to Congress: Slow down, reconsider AHCA

March 17, 2017
At a recent National Press Club event, the AMA, American Cancer Society Cancer Action Network, American Diabetes Association and American Heart…

In the Journals

ADA recommends metformin to treat type 2 diabetes

March 13, 2017
Annals of Internal Medicine today published a synopsis focusing on the updated 2017 American Diabetes Association Standards of Medical Care in…

In the Journals Plus

Vildagliptin, metformin increase heart rate after meals in type 2 diabetes

March 9, 2017
The DPP-IV inhibitor vildagliptin and metformin may both lead to an increased heart rate after eating in adults with type 2 diabetes, but the agents…

Meeting News

Gluten-free diets may be linked to increased type 2 diabetes risk

March 9, 2017
Frequent consumption of gluten may be associated with a lower risk for type 2 diabetes, according to research presented at the American Heart…

In the Journals Plus

Diabetes increases all-cause mortality risk in chronic heart failure

March 8, 2017
Adults with chronic heart failure and diabetes have higher risks for all-cause death, cardiovascular death and hospitalization for worsening heart…

In the Journals Plus

Probiotic supplementation may reduce hypertension, dyslipidemia in type 2 diabetes

March 8, 2017
Adults with type 2 diabetes randomly assigned to probiotic supplementation saw a small reduction in blood pressure, total cholesterol, LDL…

Expert discusses relationship between autoimmune disease, diabetes, CVD

February 28, 2017
Many of the risk factors for heart disease, including high BP, high LDL, smoking and obesity, are well-known, but some, such as autoimmune disease…

In the Journals Plus

Obesity influences relationship between CMV infection, metabolic syndrome in women

February 28, 2017
Women with extreme obesity who are seropositive for human cytomegalovirus are less likely to develop metabolic syndrome vs. women of normal weight…

In the Journals

Reminder devices not superior to usual care for medication adherence

February 28, 2017
Among nonadherent patients who were taking up to three medications for common chronic conditions, low-cost reminder devices did not improve adherence…

More Headlines »
Advertisement
Advertisement